Hepatitis C

Showing NaN - NaN of 57

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatitis C Trial in Worldwide (BI 201335, PegIFN/RBV)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +86 more
May 31, 2016

Hepatitis C Trial in Chicago (Peginterferon alfa-2a, Ribavirin, telaprevir)

Terminated
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 11, 2016

Hepatitis C Trial in Worldwide (Daclatasvir, Telaprevir, Peginterferon alfa-2a)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +90 more
Apr 28, 2016

Hepatitis C Trial in Worldwide (TMC435, TVR)

Completed
  • Hepatitis C
  • Bakersfield, California
  • +141 more
Mar 24, 2016

Hepatitis C Trial in Worldwide (DCV/ASV/BMS-791325)

Completed
  • Hepatitis C
  • La Jolla, California
  • +65 more
Oct 9, 2015

Hepatitis C Trial in Worldwide (Daclatasvir, Asunaprevir, BMS-791325)

Completed
  • Hepatitis C
  • La Jolla, California
  • +48 more
Sep 23, 2015

Hepatitis C Trial in Worldwide (BI201335, PegIFN/RBV, Placebo)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +105 more
Aug 18, 2015

Hepatitis C Trial in United States (Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a)

Terminated
  • Hepatitis C
  • Birmingham, Alabama
  • +26 more
Jul 13, 2015

Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated Interferon Alfa-2a)

Terminated
  • Hepatitis C
  • Birmingham, Alabama
  • +58 more
Mar 3, 2015

Hepatitis C Trial in Puerto Rico, United States (TMC435, PSI-7977 (GS7977), Ribavirin)

Completed
  • Hepatitis C
  • Hoover, Alabama
  • +22 more
Jan 26, 2015

Hepatitis C, HCV, Chronic Hepatitis C Infection Trial in United States (ABT-450, ABT-072, Ribavirin)

Completed
  • Hepatitis C
  • +3 more
  • Los Angeles, California
  • +3 more
Dec 29, 2014

Hepatitis C, Human Immunodeficiency Virus Trial in Puerto Rico, United States (SOF, RBV)

Completed
  • Hepatitis C
  • Human Immunodeficiency Virus
  • Birmingham, Alabama
  • +26 more
Nov 14, 2014

Hepatitis C Trial in Belgium, United States (ACH-0141625 (Sovaprevir), Placebo, Pegylated Interferon alpha-2a)

Completed
  • Hepatitis C
  • ACH-0141625 (Sovaprevir)
  • +3 more
  • Los Angeles, California
  • +17 more
Sep 8, 2014

Hepatitis C Trial in Worldwide (biological, drug, other)

Completed
  • Hepatitis C
  • Pegylated Interferon Alfa 2a
  • +3 more
  • Birmingham, Alabama
  • +115 more
Jul 16, 2014

Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated interferon alfa 2a)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +61 more
Jul 9, 2014

Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated Interferon Alfa 2a)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +52 more
Jul 9, 2014

Hepatitis C Trial in Worldwide (TMC435, Ribavirin (R), PegIFNa-2a (P))

Completed
  • Hepatitis C
  • Los Angeles, California
  • +72 more
May 19, 2014

Hepatitis C Trial in Worldwide (TMC435, Placebo, Peg-IFN-alfa-2a (P))

Completed
  • Hepatitis C
  • La Jolla, California
  • +80 more
May 30, 2014

Hepatitis C Trial in Worldwide (Placebo, TMC435, Peginterferon alpha-2a (PegIFN alpha-2a))

Completed
  • Hepatitis C
  • Placebo
  • +3 more
  • Dothan, Alabama
  • +62 more
May 20, 2014

Hepatitis C Trial in Worldwide (Sofosbuvir, PEG, RBV)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +96 more
Mar 4, 2014

Hepatitis, Hepatitis C Trial in Worldwide (Filibuvir, Placebo)

Completed
  • Hepatitis
  • Hepatitis C
  • Anaheim, California
  • +76 more
Dec 10, 2013

Hepatitis C, HIV Trial in Worldwide (telaprevir or matching , peginterferon alfa-2a, ribavirin (fixed dose))

Completed
  • Hepatitis C
  • HIV Infections
  • telaprevir or matching placebo
  • +3 more
  • Beverly Hills, California
  • +15 more
Aug 2, 2013

Hepatitis C Trial in United States (LADR Treatment)

Completed
  • Hepatitis C
  • LADR Treatment
  • Los Angeles, California
  • +7 more
Apr 11, 2013

Hepatitis C Virus Infection in HIV-Infected Children

Completed
  • HIV Infections
  • Hepatitis C
    • Birmingham, Alabama
    • +38 more
    Oct 30, 2012